Advance your drug discovery program with integrated biology capabilities spanning biochemical and cellular assays, CRISPR gene editing, stable cell line generation, recombinant protein production, PROTAC evaluation, biophysics, and fragment-based drug discovery. BioDuro’s experienced scientists deliver decision-ready data to support target validation, hit identification, lead optimization, and translational research.

• Broad expertise across target classes and therapeutic areas
• Biochemical, cellular, phenotypic, and protein marker-based assays
• CRISPR gene editing and custom stable cell line generation
• PROTAC discovery and degradation assay platforms
• SPR and BLI services for drug-target interaction studies
• Fragment-based drug discovery and screening capabilities
• Support for oncology, immunology, and metabolic disease programs